[논문]Nonalcoholic fatty liver disease

Erickson, Sandra K.

doi:10.1194/jlr.r800089-jlr200

Nonalcoholic fatty liver disease 원문보기

Journal of lipid research, v.50 suppl., 2009년, pp.S412 - S416

Erickson, Sandra K.

Abstract ▼ AI-Helper

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States and, indeed, worldwide. It has become a global public health issue. In the United States, the prevalence in the general population is estimated at approximately 20%, while that in the morbidly obese population at approximately 75-92% and in the pediatric population at approximately 13-14%. The progressive form of NAFLD, nonalcoholic steatohepatitis, is estimated at approximately 3-5%, with approximately 3-5% of these having progressed to cirrhosis. Thus, the numbers of individuals at risk for end-stage liver disease and development of primary liver cancer is large. NAFLD is an independent risk factor for cardiovascular disease, leads to increased all-cause mortality, and to increased liver-related mortality. This review focuses on recent advances in our understanding of the NAFLD disease spectrum, including etiology, diagnosis, treatment, and genetic and environmental risk factors and suggests future directions for research in this important area.

참고문헌 (48)

Mayo Clin. Proc. Ludwig 55 434 1980 Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

상세보기
Semin. Liver Dis. Lazo 28 339 2008 10.1055/s-0028-1091978 The epidemiology of nonalcoholic fatty liver disease: a global perspective

상세보기
Clin. Liver Dis. Ong 11 1 2007 10.1016/j.cld.2007.02.009 Epidemiology and natural history of NAFLD and NASH

상세보기
Hepatology. Marrero 36 1349 2002 10.1002/hep.1840360609 NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States

상세보기
J. Hepatol. Bullock 41 685 2004 10.1016/j.jhep.2004.05.008 Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma

상세보기
Semin. Liver Dis. Chitturi 21 27 2001 10.1055/s-2001-12927 Etiopathogenesis of nonalcoholic steatohepatitis

상세보기
J. Clin. Endocrinol. Metab. Utzschneider 91 4753 2006 10.1210/jc.2006-0587 Review: the role of insulin resistance in nonalcoholic fatty liver disease

상세보기
Semin. Liver Dis. Ramesh 24 399 2004 10.1055/s-2004-860869 Hepatitis C and nonalcoholic fatty liver disease

상세보기
Clin. Infect. Dis. Guaraldi 47 250 2008 10.1086/589294 Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors

상세보기
Curr. HIV/AIDS Rep. Merriman 3 113 2006 10.1007/BF02696654 Nonalcoholic fatty liver disease and HIV infection

상세보기
Diabetes Care. Targher 29 1325 2006 10.2337/dc06-0135 Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease

상세보기
Dig. Dis. Sci. Aygun 53 1352 2008 10.1007/s10620-007-9998-7 Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease

상세보기
Semin. Liver Dis. Rubinstein 28 380 2008 10.1055/s-0028-1091982 Hepatic, cardiovascular and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease

상세보기
J. Hepatol. Ong 49 608 2008 10.1016/j.jhep.2008.06.018 Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease

상세보기
Am. J. Gastroenterol. Dunn 103 2263 2008 10.1111/j.1572-0241.2008.02034.x Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study

상세보기
Gastroenterology. Ratziu 128 1898 2005 10.1053/j.gastro.2005.03.084 Sampling variability of liver biopsy in nonalcoholic fatty liver disease

상세보기
Am. J. Clin. Pathol. Yeh 128 837 2007 10.1309/RTPM1PY6YGBL2G2R Pathology of nonalcoholic fatty liver disease

상세보기
Hepatology. Merriman 44 874 2006 10.1002/hep.21346 Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

상세보기
Hepatology. Angulo 45 846 2007 10.1002/hep.21496 The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD

상세보기
J. Gastrointestin. Liver Dis. Munteanu 17 187 2008 Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: Fibro Test-Fibro-Max™ Experience
Semin. Liver Dis. Wieckowska 28 386 2008 10.1055/s-0028-1091983 Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive

상세보기
Hepatology. Mofrad 37 1286 2003 10.1053/jhep.2003.50229 Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

상세보기
Semin. Liver Dis. Schwimmer 27 312 2007 10.1055/s-2007-985075 Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents

상세보기
J. Clin. Endocrinol. Metab. Kershaw 89 2548 2004 10.1210/jc.2004-0395 Adipose tissue as an endocrine organ

상세보기
Hepatology. Maher 48 670 2008 10.1002/hep.22399 Beyond insulin resistance: innate immunity in nonalcoholic steatohepatitis

상세보기
Semin. Liver Dis. Jou 28 370 2008 10.1055/s-0028-1091981 Mechanisms of disease progression in nonalcoholic fatty liver disease

상세보기
Am. J. Gastroenterol. Willner 96 2957 2001 10.1111/j.1572-0241.2001.04667.x Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency and severity of disease

상세보기
Am. J. Med. Struben 108 9 2000 10.1016/S0002-9343(99)00315-0 Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds

상세보기
Ann. Hepatol. Osterreicher 6 83 2007 10.1016/S1665-2681(19)31936-2 The genetics of nonalcoholic fatty liver disease

상세보기
Am. J. Gastroenterol. Caldwell 97 1496 2002 10.1111/j.1572-0241.2002.05795.x Is NASH underdiagnosed among African Americans?

상세보기
Hepatology. Browning 40 1387 2004 10.1002/hep.20466 Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

상세보기
Am. J. Gastroenterol. Browning 99 292 2004 10.1111/j.1572-0241.2004.04059.x Ethnic differences in the prevalence of cryptogenic cirrhosis

상세보기
Hepatology. Weston 41 372 2005 10.1002/hep.20554 Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease

상세보기
Proc. Natl. Acad. Sci. USA. Petersen 103 18273 2006 10.1073/pnas.0608537103 Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men

상세보기
J. Gastroenterol. Hepatol. Amarapurkar 22 788 2007 10.1111/j.1440-1746.2007.05042.x How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?

상세보기
J. Gastroenterol. Hepatol. Fan 22 794 2007 10.1111/j.1440-1746.2007.04952.x What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?

상세보기
Nat. Genet. Romeo 40 1461 2008 10.1038/ng.257 Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

상세보기
Hepatology. Musso 47 1167 2008 10.1002/hep.22142 Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: possible pathogenetic role in NASH

상세보기
J. Hepatol. Solga 38 681 2003 10.1016/S0168-8278(03)00097-7 Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics

상세보기
Int. J. Exp. Pathol. Anstee 87 1 2006 10.1111/j.0959-9673.2006.00465.x Mouse models in non-alcoholic fatty liver disease and steatohepatitis research

상세보기
Semin. Liver Dis. Rafiq 28 427 2008 10.1055/s-0028-1091986 Effects of weight loss on nonalcoholic fatty liver disease

상세보기
Am. J. Clin. Nutr. Zivkovic 86 285 2007 10.1093/ajcn/86.2.285 Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease

상세보기
Semin. Liver Dis. Verna 28 407 2008 10.1055/s-0028-1091985 Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery

상세보기
Hepatology. Browning 44 466 2006 10.1002/hep.21248 Statins and hepatic steatosis: perspectives from the Dallas Heart Study

상세보기
Gastroenterology. Ratziu 135 100 2008 10.1053/j.gastro.2008.03.078 Rosiglitazone for nonalcoholic steatohepatitis: one year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) trial

상세보기
Gastroenterology. Guruprasad 135 1176 2008 10.1053/j.gastro.2008.06.047 Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

상세보기
Semin. Liver Dis. Kashi 28 396 2008 10.1055/s-0028-1091984 Current and emerging therapies in nonalcoholic fatty liver disease

상세보기
Hepatology. Bellentani 47 746 2008 10.1002/hep.22009 Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach

상세보기

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Nonalcoholic fatty liver disease 원문보기

Abstract ▼ AI-Helper

참고문헌 (48)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트